Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Trial of Pegaptanib for Diabetic Macular Edema
NCT00040313Phase 2Completed
- Sponsor
- OSI Eyetech
- Start
- Oct 2002
- Modality
- Antisense DNA, RNA Aptamers, Small Interfering RNA (siRNA)
01
Overview
A Phase 2 trial of pegaptanib sodium in diabetic macular edema (DME), sponsored by OSI Eyetech. Started Oct 2002; status: completed.
02
Drugs
pegaptanib sodium
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00040313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00040313.